The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Cryptococcus


High impact information on Cryptococcus


Chemical compound and disease context of Cryptococcus


Biological context of Cryptococcus


Anatomical context of Cryptococcus


Associations of Cryptococcus with chemical compounds


Gene context of Cryptococcus


Analytical, diagnostic and therapeutic context of Cryptococcus


  1. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Edman, J.C., Kwon-Chung, K.J. Mol. Cell. Biol. (1990) [Pubmed]
  2. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. Fleuridor, R., Lees, A., Pirofski, L. J. Immunol. (2001) [Pubmed]
  3. The role and mechanism of diacylglycerol-protein kinase C1 signaling in melanogenesis by Cryptococcus neoformans. Heung, L.J., Kaiser, A.E., Luberto, C., Del Poeta, M. J. Biol. Chem. (2005) [Pubmed]
  4. Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide. Valadon, P., Nussbaum, G., Oh, J., Scharff, M.D. J. Immunol. (1998) [Pubmed]
  5. Priming with IFN-gamma restores deficient IL-12 production by peripheral blood mononuclear cells from HIV-seropositive donors. Harrison, T.S., Levitz, S.M. J. Immunol. (1997) [Pubmed]
  6. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Taborda, C.P., Casadevall, A. Immunity (2002) [Pubmed]
  7. Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. Yuan, R., Clynes, R., Oh, J., Ravetch, J.V., Scharff, M.D. J. Exp. Med. (1998) [Pubmed]
  8. Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. Nussbaum, G., Cleare, W., Casadevall, A., Scharff, M.D., Valadon, P. J. Exp. Med. (1997) [Pubmed]
  9. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. Salas, S.D., Bennett, J.E., Kwon-Chung, K.J., Perfect, J.R., Williamson, P.R. J. Exp. Med. (1996) [Pubmed]
  10. The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies. Casadevall, A., Scharff, M.D. J. Exp. Med. (1991) [Pubmed]
  11. Radiation inactivation analysis of enzymes. Effect of free radical scavengers on apparent target sizes. Eichler, D.C., Solomonson, L.P., Barber, M.J., McCreery, M.J., Ness, G.C. J. Biol. Chem. (1987) [Pubmed]
  12. Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir. Polsky, B., Depman, M.R., Gold, J.W., Galicich, J.H., Armstrong, D. Am. J. Med. (1986) [Pubmed]
  13. HIV type 1 envelope glycoprotein gp120 induces development of a T helper type 2 response to Cryptococcus neoformans. Pietrella, D., Monari, C., Retini, C., Palazzetti, B., Kozel, T.R., Vecchiarelli, A. AIDS (1999) [Pubmed]
  14. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. Schwarz, P., Dromer, F., Lortholary, O., Dannaoui, E. Antimicrob. Agents Chemother. (2006) [Pubmed]
  15. Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage. Currie, B., Sanati, H., Ibrahim, A.S., Edwards, J.E., Casadevall, A., Ghannoum, M.A. Antimicrob. Agents Chemother. (1995) [Pubmed]
  16. Identification of the MATa mating-type locus of Cryptococcus neoformans reveals a serotype A MATa strain thought to have been extinct. Lengeler, K.B., Wang, P., Cox, G.M., Perfect, J.R., Heitman, J. Proc. Natl. Acad. Sci. U.S.A. (2000) [Pubmed]
  17. Gene prediction and verification in a compact genome with numerous small introns. Tenney, A.E., Brown, R.H., Vaske, C., Lodge, J.K., Doering, T.L., Brent, M.R. Genome Res. (2004) [Pubmed]
  18. The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. Olszewski, M.A., Huffnagle, G.B., McDonald, R.A., Lindell, D.M., Moore, B.B., Cook, D.N., Toews, G.B. J. Immunol. (2000) [Pubmed]
  19. Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. Huffnagle, G.B., McNeil, L.K., McDonald, R.A., Murphy, J.W., Toews, G.B., Maeda, N., Kuziel, W.A. J. Immunol. (1999) [Pubmed]
  20. Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. Chaka, W., Verheul, A.F., Vaishnav, V.V., Cherniak, R., Scharringa, J., Verhoef, J., Snippe, H., Hoepelman, A.I. J. Immunol. (1997) [Pubmed]
  21. Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro. Levitz, S.M., Dupont, M.P. J. Clin. Invest. (1993) [Pubmed]
  22. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Steinbakk, M., Naess-Andresen, C.F., Lingaas, E., Dale, I., Brandtzaeg, P., Fagerhol, M.K. Lancet (1990) [Pubmed]
  23. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Tucker, S.C., Casadevall, A. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
  24. CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15. Ma, L.L., Spurrell, J.C., Wang, J.F., Neely, G.G., Epelman, S., Krensky, A.M., Mody, C.H. J. Immunol. (2002) [Pubmed]
  25. Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates. Chaturvedi, V., Wong, B., Newman, S.L. J. Immunol. (1996) [Pubmed]
  26. Calcineurin is required for virulence of Cryptococcus neoformans. Odom, A., Muir, S., Lim, E., Toffaletti, D.L., Perfect, J., Heitman, J. EMBO J. (1997) [Pubmed]
  27. Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS. Bozzette, S.A., Larsen, R.A., Chiu, J., Leal, M.A., Tilles, J.G., Richman, D.D., Leedom, J.M., McCutchan, J.A. Ann. Intern. Med. (1991) [Pubmed]
  28. Antifungal susceptibility testing: practical aspects and current challenges. Rex, J.H., Pfaller, M.A., Walsh, T.J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M.A., Gosey, L.L., Odds, F.C., Rinaldi, M.G., Sheehan, D.J., Warnock, D.W. Clin. Microbiol. Rev. (2001) [Pubmed]
  29. Functional cloning and characterization of a UDP- glucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis. Bar-Peled, M., Griffith, C.L., Doering, T.L. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  30. Pathogenic roles for fungal melanins. Jacobson, E.S. Clin. Microbiol. Rev. (2000) [Pubmed]
  31. The second STE12 homologue of Cryptococcus neoformans is MATa-specific and plays an important role in virulence. Chang, Y.C., Penoyer, L.A., Kwon-Chung, K.J. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  32. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. Shoham, S., Huang, C., Chen, J.M., Golenbock, D.T., Levitz, S.M. J. Immunol. (2001) [Pubmed]
  33. Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. Traynor, T.R., Herring, A.C., Dorf, M.E., Kuziel, W.A., Toews, G.B., Huffnagle, G.B. J. Immunol. (2002) [Pubmed]
  34. Toll-like receptors and innate antifungal responses. Roeder, A., Kirschning, C.J., Rupec, R.A., Schaller, M., Korting, H.C. Trends Microbiol. (2004) [Pubmed]
  35. RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans. Alspaugh, J.A., Cavallo, L.M., Perfect, J.R., Heitman, J. Mol. Microbiol. (2000) [Pubmed]
  36. Cryptococcus albidus-induced summer-type hypersensitivity pneumonitis. Miyagawa, T., Hamagami, S., Tanigawa, N. Am. J. Respir. Crit. Care Med. (2000) [Pubmed]
  37. Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay. Belay, T., Cherniak, R. Infect. Immun. (1995) [Pubmed]
  38. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Sanford, J.E., Lupan, D.M., Schlageter, A.M., Kozel, T.R. Infect. Immun. (1990) [Pubmed]
  39. In vivo complement activation and binding of C3 to encapsulated Cryptococcus neoformans. Truelsen, K., Young, T., Kozel, T.R. Infect. Immun. (1992) [Pubmed]
  40. Cloning of a Cryptococcus neoformans gene, GPA1, encoding a G-protein alpha-subunit homolog. Tolkacheva, T., McNamara, P., Piekarz, E., Courchesne, W. Infect. Immun. (1994) [Pubmed]
WikiGenes - Universities